found that in the lungs of patients with severe COVID-19, macrophages exacerbate inflammation by producing chemokines that recruit neutrophils to the site of infection through chemokine receptors CC-chemokine receptor 1 (CCR1) and C-X-C chemokine receptor type 2 (CXCR2) (57). Here, CXCR2 is linked to COVID-19.